GB-115

2025-05-08:

GB-115 #

• Cholecystokinin receptor A (CCK-A) antagonist. = downregulation rather than upregulatio, so benefits should compound.
  • Much stronger antagonists such as proglumide showed minimal side effects besides occasional cholestasis. Good thing I’m a low fat diet chad I guess